GEMKOM intends to meet the global gold-standard of cannabis commodity cultivation.

To this end, our cultivation facility is highly complex and customised to meet the unique specifications and needs of each operation. Fully integrated critical systems ensure optimal performance, enabling us to deliver successful cultivation results, with repeatability, and at scale.

This cultivation strategy is designed to sit neatly within our smart farming, low energy approach. It is an entirely soil-free, indoor, input-controlled strategy designed to produce a specifically tailored end product with high yields and a year round harvest cycle.

In addition, the strategy is data driven, optimised, R&D focused, and taps into the potential (commercial and agricultural) of GMP and breeding technologies. The goal is to create repeatable, scalable, tailored strains for existing and emerging markets across the medicinal spectrum.

With an emphasis on producing ‘pharmaceutical grade’ cannabis products (dry flower, biomass), we will operate a ‘research class’ facility with laboratory standards. This grade of production aims to replicate near-perfect consistency in cannabinoid profile and product result.

From a production perspective, cannabis grown indoors has been shown to yield higher when compared with outdoor and greenhouse operations. Planting density, shorter production cycles and precision input control (temperature, lighting, air flow, etc) serve to underwrite improved yields and downstream value.

NB: For efficiency of production and to ensure quality (especially in smokable flower markets) facilities often produce smaller scale and highly ‘clean’ products.

Our comprehensive cultivation space modelling enables core functions to work hand in hand to produce economically competitive high-value crops efficiently and consistently. Plus, our modelling (with bench layout and design) allows for maximum canopy space.

Our cultivation strategy is predicted to achieve the following:

For predictable cannabinoid yield, effective lighting is necessary. Light intensity positively impacts cannabis API (cannabinoids). These metabolites effectively define a company’s bottom line.

No production method is better than indoor cultivation for pushing APIs (with lighting, CO2, HVAC, and irrigation controls). Our automated and customised water and fertigation system is designed for large-scale indoor agriculture, and to maintain crop consistency and reliability.

In turn, this allows for extraction processes to isolate desired cannabinoids for pharmaceutical, medical or research use, and GMP dried flower for smokables.

GEMKOM’s cultivation strategy will continue to drive innovation in controlled indoor environments.

All herbal medicines are inherently variable. For this reason, the input controls of indoor cultivation work best within medicinal and regulatory frameworks. Discerning health authorities and patients have known this for some time.

Further reducing variables, most notably human error, is targeted automation across the cultivation cycle. This will be backed up by extensive monitoring and contingency mechanisms to ensure environment stabilisation and real-time data flows.

Pros of indoor cannabis cultivation:

Meanwhile, on the con side, it is capital and energy intensive, meaning there are start-up barriers and energy and environmental challenges.

Products and markets include: